3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
44
Phase 3
8
Phase 1
8
Phase 1/2
7
Phase 4
3
Phase NA
1
Phase EARLY_PHASE1
1
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Multiple Myeloma
5
Lymphoma, Non-Hodgkin
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Hairy Cell
3
Hematologic Neoplasms
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Sezary Syndrome
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Hodgkin Disease
2
Congenital Abnormalities
2
Breast Neoplasms
2
Teratoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Paraproteinemias
1
Interventions
Cyclophosphamide
25
Rituximab
18
fludarabine phosphate
15
Radiotherapy
13
Methotrexate
13
Peripheral Blood Stem Cell Transplantation
12
Filgrastim
12
Cytarabine
12
Vincristine
11
Melphalan
10
Cyclosporine
10
Busulfan
10
Antilymphocyte Serum
10
Exercise
9
Doxorubicin
9
Prednisone
7
Mycophenolic Acid
7
Magnetic Resonance Spectroscopy
7
Etoposide
7
Early Intervention, Educational
7
Whole-Body Irradiation
6
Surveys and Questionnaires
6
Prednisolone
6
Palliative Care
6
Methods
6
Leucovorin
6
Educational Status
6
Blood Specimen Collection
6
Dexamethasone
5
pegylated granulocyte colony-stimulating factor
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT01186224
2025-03-17
PHANTASTIC
University of Liverpool
Phase NA
Completed
60 enrolled